Pondel K, Kawałko K, Bielewicz K, Chmura A, Karaś A. Effect of glucagon-like peptide-1 (GLP-1) agonists on the example of semaglutide on the cardiovascular system and their role in the treatment of obesity. J Educ Health Sport [Internet]. 2022 Aug. 30 [cited 2024 Aug. 16];12(9):55-60. Available from: https://apcz.umk.pl/JEHS/article/view/39508